why novartis� landmark cancer drug approval is great news for bluebird
., seventh-highest in the nation, and more than double the national average.
.
more
.
"there is an issue that needs to be addressed in terms of the narrative the health trust tried to present and mislead the inquest and cover up what actually happened.
.
china is host to 70 percent of all car cell therapy trials registered in 2017 and the first four months of 2018 (150 out of 214).
.
.
.